International Biotechnology Trust PLC Chinook Therapeutics, Inc. Transaction History

International Biotechnology Trust PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 18, 2023	SELL	$21.53 - $26.8 $439,212 - $546,720	-20,400 Reduced 5.99%	319,989 $7.41 Million
Q3 2022 Nov 08, 2022	BUY	$17.51 - $23.37 $5.86 Million - $7.82 Million	334,442 Added 5623.71%	340,389 $6.69 Million
Q2 2022 Aug 16, 2022	SELL	$12.59 - $18.8 $4.21 Million - $6.29 Million	-334,442 Reduced 98.25%	5,947 $340 Million
Q1 2022 May 20, 2022	BUY	$12.02 - $16.69 $613,020 - $851,190	51,000 Added 17.62%	340,389 $5.57 Million
Q4 2021 Feb 15, 2022	BUY	$10.69 - $16.83 $581,418 - $915,366	54,389 Added 23.14%	289,389 $4.71 Million
Q3 2021 Nov 12, 2021	BUY	$11.5 - $14.86 $738,058 - $953,699	64,179 Added 37.57%	235,000 $2.99 Million
Q2 2021 Aug 11, 2021	BUY	$13.6 - $18.98 $2.32 Million - $3.24 Million	170,821 New	170,821 $2.41 Million

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.